-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Td3qIV6famPmn42NAfbnGNzXMGMLph937Qww1pX3cB5XvBWmohF1aTWxYmGBAxcm R/npcEgjuS1HnVLxL0/Gkg== 0001144204-09-036903.txt : 20090710 0001144204-09-036903.hdr.sgml : 20090710 20090710180520 ACCESSION NUMBER: 0001144204-09-036903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090708 FILED AS OF DATE: 20090710 DATE AS OF CHANGE: 20090710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERNSTEIN DREW CENTRAL INDEX KEY: 0001466250 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 09940886 MAIL ADDRESS: STREET 1: C/O BERSTEIN & PINCHUK LLP STREET 2: SEVEN PENN PLAZA SUITE 830 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 4 1 v154577_ex.xml X0303 4 2009-07-08 0 0000320017 NeoStem, Inc. NBS 0001466250 BERNSTEIN DREW C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 1 0 0 0 Stock Options (right to buy) 1.71 2009-07-08 4 A 0 200000 0 A 2019-07-08 Common Stock, par value $0.001 per share 200000 200000 D On July 8, 2009, the date of grant (the "Grant Date"), the reporting person was granted an option to purchase 200,000 shares of common stock, par value $0.001 per share, of NeoStem, Inc. (the "Company") pursuant and subject to the Company's 2009 Equity Compensation Plan. The option vests as to 67,000 shares on the first and second anniversary of the Grant Date and as to the remaining 66,000 shares on the third anniversary of the Grant Date. Drew Bernstein, By: /s/ Catherine M. Vaczy as attorney-in-fact 2009-07-10 -----END PRIVACY-ENHANCED MESSAGE-----